Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2178534Generated: October 30, 2026

Potassium Carbonate → 4-[(1-{2-[2-(2-Oxopiperidin-1-yl)phenyl]ethyl}azetidin-3-yl)oxy]benzonitrile oxalate

https://huagongshe.com/reaction/2178534

Reaction equation

Participants

RoleNameHCIDCharge
ReactantPotassium CarbonateHCID 11430—
Reactant4-CyanophenolHCID 13019—
Reactant1-{2-[2-(2-Oxopiperidin-1-yl)phenyl]ethyl}azetidin-3-yl methanesulfonateHCID 89500550—
SolventAcetonitrileHCID 6342—
Solventacetonitrile CH2Cl2 MeOH DMFHCID 131733029—
Product4-[(1-{2-[2-(2-Oxopiperidin-1-yl)phenyl]ethyl}azetidin-3-yl)oxy]benzonitrile oxalateHCID 71522274—

Reaction Conditions

Temperature100 °C

Reaction Steps

To 1-{2-[2-(2-oxopiperidin-1-yl)phenyl]ethyl}azetidin-3-yl methanesulfonate a11-2 (273 mg, 0.775 mmol, 1 eq) and 4-hydroxybenzonitrile (110.8 mg, 0.93 mmol, 1.2 eq) in acetonitrile (5 ml) is added, under stirring, K2CO3 (374.9 mg, 2.71 mmol, 3.5 eq). The reaction mixture is heated at 100° C. for 10 minutes under microwave conditions. The reaction mixture is cooled, diluted with a mixture of acetonitrile/CH2Cl2/MeOH/DMF (1/1/1/1) (approximately 10 ml) to ensure the solubilisation of the expected product. The suspension obtained is loaded on an ion exchange acidic resin cartridge (2 g) prewashed with methanol. The cartridge is washed with approximately 3 column volumes of methanol, then eluted with 3 column volumes of 1M ammonia in methanol. The eluate is evaporated to dryness and the crude material is purified by reverse phase chromatography (gradient: acetonitrile//H2O/NH4OH from 40/60/0.1 to 70/30/0.1 in 10 minutes). The residue obtained is dissolved in acetone (approximately 2 ml) and oxalic acid (4.4 mg, 0.05 mmole, 1 eq) in acetone (2 ml) is added. This solution is evaporated slowly and some crystals appear. Acetone (approximately 2 ml) then diethylether (approximately 10 ml) are added to give a white precipitate which is filtrated, extensively washed with diethylether and dried overnight at 40° C. under vacuum to afford 15.5 mg of 4-[(1-{2-[2-(2-oxopiperidin-1-yl)phenyl]ethyl}azetidin-3-yl)oxy]benzonitrile oxalate 55.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09067930B2
Source datasetuspto-grants-2015_06
ORD IDord-de5570e68ffc4cfc8537cdffa0495dc9
Source noteuspto-grants-2015_06